Epilepsy-associated bone mineral density loss should be prevented.
Trevathan
Edwin
E
D000293:Adolescent; D000328:Adult; D000375:Aging / Q000502:physiology*; D000927:Anticonvulsants / Q000009:adverse effects; D015519:Bone Density / Q000187:drug effects / Q000235:genetics*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001846:Bone Development / Q000187:drug effects / Q000235:genetics*; D001851:Bone Diseases, Metabolic / Q000175:diagnosis* / Q000209:etiology* / Q000517:prevention & control; D002675:Child, Preschool; D042241:Early Diagnosis; D004827:Epilepsy / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000592:standards
D000927:Anticonvulsants; D050071:Bone Density Conservation Agents